We noticed you’re blocking ads

Thanks for visiting CRSTG | Europe Edition. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstodayeurope.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Innovations | Jul/Aug 2013



Incise Microincision IOL

Company Bausch + Lomb
Phone +44 20 8781 2900
Web bausch.com
An IOL designed for microincision cataract surgery.
Key Features

  • Made of enhanced acrylic material and featuring an advanced aspheric optic
  • Designed for implantation through a sub–2-mm incision
  • Has a 360° barrier edge with a radius of curvature of 5 μm to minimize posterior capsular opacification

Bausch + Lomb recently launched the Incise Microincision IOL in Europe. According to company literature, the Incise IOL’s advanced aspheric optic is designed to improve visual quality. The combination of this acrylic IOL with the Stellaris Vision Enhancement System’s improved capabilities and the singleuse Incise Viscoject Bioinjector enables 1.8-mm in-the-bag and 1.4-mm woundassisted implantation. The Incise IOL is designed to minimize posterior capsular opacification with its 360º square-edge design and radius of curvature of 5 μm.